Recently, Zhang et al. administered 200 mg/kg/day of butyrate in HFD-induced NAFLD mice and found that it was negatively associated with FBS and IR; however, the intervention with butyrate failed to alter insulin concentrations (32). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.